Anesketin : Presence of particulate matter in the affected lots

Product quality

Date

2025-07-07

Country

Canada

Product

Anesketin 100 mg/mL solution for injection

Classification

Type II

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2025-07-09
2. CA
   Drugs & medicalType II

   Mobile Power Unit

   Performance

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType II

   EVair

   Performance

   Health CanadaOfficial notice →
4. 2025-07-08
5. CA
   Drugs & medicalType I

   NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets

   Product safety

   Health CanadaOfficial notice →
6. 2025-07-07
7. CA
   Drugs & medical

   NRA-Amlodipine 5 mg tablets: One lot recalled as some bottles may contain the wrong drug

   Product safety

   Health CanadaOfficial notice →
8. 2025-07-04
9. CA
   Drugs & medicalType II

   Biofinity® Toric Multifocal and XR Toric

   Labelling and packaging - Sterility

   Health CanadaOfficial notice →
10. CA
    Drugs & medicalType I

    PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidate

    Product quality

    Health CanadaOfficial notice →